Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.

The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Report Scope

The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report

Report Metric	Details
Report Name	Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
CAGR	5%
Segment by Type	Aspirin Ibuprofen Naproxen Celecoxib Others
Segment by Application	Drug Store Hospital Pharmacies Online
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche (Genentech), Amgen, B-MS, Merck, Pfizer, Novartis, Eli Lilly and Company, Johnson & Johnson, GSK, Sanofi, Boehringer Ingelheim, Zhejiang Jiuzhou Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report?

Ans: The main players in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market are Roche (Genentech), Amgen, B-MS, Merck, Pfizer, Novartis, Eli Lilly and Company, Johnson & Johnson, GSK, Sanofi, Boehringer Ingelheim, Zhejiang Jiuzhou Pharmaceutical

What are the Application segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report?

Ans: The Applications covered in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report are Drug Store, Hospital Pharmacies, Online

What are the Type segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report?

Ans: The Types covered in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report are Aspirin, Ibuprofen, Naproxen, Celecoxib, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Aspirin

1.2.3 Ibuprofen

1.2.4 Naproxen

1.2.5 Celecoxib

1.2.6 Others

1.3 Market by Application

1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Drug Store

1.3.3 Hospital Pharmacies

1.3.4 Online

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2019-2030)

2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Region

2.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region (2019-2024)

2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2025-2030)

2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics

2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends

2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers

2.3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges

2.3.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue

3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2019-2024)

3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2019-2024)

3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue

3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio

3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2023

3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served

3.6 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service

3.7 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type

4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2019-2024)

4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2025-2030)

5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application

5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2019-2024)

5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024)

6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024)

7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2019-2024)

8.4 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

9.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024)

9.4 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024)

10.4 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche (Genentech)

11.1.1 Roche (Genentech) Company Detail

11.1.2 Roche (Genentech) Business Overview

11.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.1.5 Roche (Genentech) Recent Development

11.2 Amgen

11.2.1 Amgen Company Detail

11.2.2 Amgen Business Overview

11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.2.5 Amgen Recent Development

11.3 B-MS

11.3.1 B-MS Company Detail

11.3.2 B-MS Business Overview

11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.3.5 B-MS Recent Development

11.4 Merck

11.4.1 Merck Company Detail

11.4.2 Merck Business Overview

11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.4.5 Merck Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Detail

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.5.5 Pfizer Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.6.5 Novartis Recent Development

11.7 Eli Lilly and Company

11.7.1 Eli Lilly and Company Company Detail

11.7.2 Eli Lilly and Company Business Overview

11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.7.5 Eli Lilly and Company Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Detail

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.8.5 Johnson & Johnson Recent Development

11.9 GSK

11.9.1 GSK Company Detail

11.9.2 GSK Business Overview

11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.9.5 GSK Recent Development

11.10 Sanofi

11.10.1 Sanofi Company Detail

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.10.5 Sanofi Recent Development

11.11 Boehringer Ingelheim

11.11.1 Boehringer Ingelheim Company Detail

11.11.2 Boehringer Ingelheim Business Overview

11.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.11.5 Boehringer Ingelheim Recent Development

11.12 Zhejiang Jiuzhou Pharmaceutical

11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Detail

11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview

11.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Eli Lilly and Company

Zhejiang Jiuzhou Pharmaceutical

List of Tables

Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Aspirin

Table 3. Key Players of Ibuprofen

Table 4. Key Players of Naproxen

Table 5. Key Players of Celecoxib

Table 6. Key Players of Others

Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2019-2024)

Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2025-2030)

Table 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends

Table 14. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers

Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges

Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2019-2024)

Table 19. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2023)

Table 20. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service

Table 24. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2019-2024)

Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2025-2030)

Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2019-2024)

Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2025-2030)

Table 34. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)

Table 49. Roche (Genentech) Company Detail

Table 50. Roche (Genentech) Business Overview

Table 51. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 52. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 53. Roche (Genentech) Recent Development

Table 54. Amgen Company Detail

Table 55. Amgen Business Overview

Table 56. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 57. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 58. Amgen Recent Development

Table 59. B-MS Company Detail

Table 60. B-MS Business Overview

Table 61. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 62. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 63. B-MS Recent Development

Table 64. Merck Company Detail

Table 65. Merck Business Overview

Table 66. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 67. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 68. Merck Recent Development

Table 69. Pfizer Company Detail

Table 70. Pfizer Business Overview

Table 71. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 72. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 73. Pfizer Recent Development

Table 74. Novartis Company Detail

Table 75. Novartis Business Overview

Table 76. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 77. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 78. Novartis Recent Development

Table 79. Eli Lilly and Company Company Detail

Table 80. Eli Lilly and Company Business Overview

Table 81. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 82. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 83. Eli Lilly and Company Recent Development

Table 84. Johnson & Johnson Company Detail

Table 85. Johnson & Johnson Business Overview

Table 86. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 87. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 88. Johnson & Johnson Recent Development

Table 89. GSK Company Detail

Table 90. GSK Business Overview

Table 91. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 92. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 93. GSK Recent Development

Table 94. Sanofi Company Detail

Table 95. Sanofi Business Overview

Table 96. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 97. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 98. Sanofi Recent Development

Table 99. Boehringer Ingelheim Company Detail

Table 100. Boehringer Ingelheim Business Overview

Table 101. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 102. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 103. Boehringer Ingelheim Recent Development

Table 104. Zhejiang Jiuzhou Pharmaceutical Company Detail

Table 105. Zhejiang Jiuzhou Pharmaceutical Business Overview

Table 106. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 107. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 108. Zhejiang Jiuzhou Pharmaceutical Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2023 VS 2030

Figure 3. Aspirin Features

Figure 4. Ibuprofen Features

Figure 5. Naproxen Features

Figure 6. Celecoxib Features

Figure 7. Others Features

Figure 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2023 VS 2030

Figure 10. Drug Store Case Studies

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Online Case Studies

Figure 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered

Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region: 2023 VS 2030

Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2023

Figure 18. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2023

Figure 20. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)

Figure 22. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)

Figure 26. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2019-2030)

Figure 34. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)

Figure 42. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)

Figure 46. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 49. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 50. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 51. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 52. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 53. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 54. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 55. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 56. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 57. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 58. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 59. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions